Protein misfolding is a common event in living cells. In young and healthy cells, the misfolded protein load is disposed of by protein quality control (PQC) systems. In aging cells and in cells from certain individuals with genetic diseases, the load may overwhelm the PQC capacity, resulting in accumulation of misfolded proteins. Dependent on the properties of the protein and the efficiency of the PQC systems, the accumulated protein may be degraded or assembled into toxic oligomers and aggregates. To illustrate this concept, we discuss a number of very different protein misfolding diseases including phenylketonuria, Parkinson's disease, α-1-antitrypsin deficiency, familial neurohypophyseal diabetes insipidus, and shortchain acyl-CoA dehydrogenase deficiency. Despite the differences, an emerging paradigm suggests that the cellular effects of protein misfolding provide a common framework that may contribute to the elucidation of the cell pathology and guide intervention and treatment strategies of many genetic and age-dependent diseases.
INTRODUCTION
The function of most cellular proteins is dependent on their three-dimensional structure, which is acquired through folding of the polypeptide chain coded from the nuclear genome and-for 13 mitochondrial proteins-the mitochondrial DNA. Changes in the polypeptide chain, either resulting from inherited or acquired gene variations or from abnormal amino acid modifications, may change the folding process and give rise to misfolding of the protein. Depending on the nature of the protein itself, the cellular compartment in which the misfolding occurs, the activity of the folding and degradation machineries as well as interacting genetic factors and the cell and environmental conditions, the consequences of the misfolding may be quite different. However, despite this diversity, a large number of very different diseases, from early-onset inborn errors of metabolism to late-onset neurodegenerative diseases, can be viewed as protein misfolding diseases, often called conformational diseases (39, 88) . On this basis, a common framework related to the molecular pathogenesis and cell pathologic mechanisms in these very different diseases is emerging.
In this review we introduce the theory of protein folding and misfolding in general and mention the emerging ways to predict consequences of amino acid alterations. We introduce the concept of protein quality control (PQC) and discuss the various compartmentspecific PQC systems as well as the molecular pathogenesis of some representative misfolding diseases originating in the various compartments. In the last sections we discuss some of the cellular consequences of accumulated misfolded proteins.
PROTEIN FOLDING AND MISFOLDING: THE ROLE OF GENE VARIATIONS
As Anfinsen showed in 1973, the amino acid sequence of a polypeptide chain contains all necessary information determining the threedimensional functional structure of a given protein (2) . The question is how this structure is achieved in the living cell. Statistically, there are an astronomical number of possible conformations for a given polypeptide. The Levinthal paradox states that a random search for the final conformation would take millions of years (56). To overcome this obstacle, nature uses a number of biochemical "rules" and has evolved some assisting components facilitating the folding processes, the socalled molecular chaperones (28). Molecular chaperones assist the folding by protecting the protein during the folding process and keeping it away from misfolding, which may lead to aggregation. The target for chaperones is unfolded and partially folded polypeptide chains with exposed stretches of hydrophobic amino acids that are usually sequestered in the core of folded proteins. Proteins with exposed hydrophobic stretches are reversibly bound to and released from the chaperones. Many chaperones have an ATPase domain that orchestrates conformational changes, switching the molecule between high and low binding affinity states (35) .
The driving force of protein folding is the search for a conformation with lower free energy than the previous one. The various lower energy states can be separated by barriers of higher energy, and to overcome these barriers chaperone assistance may be required. A certain hierarchy of interactions seems to exist between residues for the first part of the folding process, the so-called nucleationcondensation process, which speeds up the folding through a number of transition states characterized by the presence of interatomic interactions also present in the native protein (33, 60).
To picture protein folding, a topological landscape representing different energy levels has been suggested. In this model the process of folding is described as a constant striving toward minimal free energy with the native structure of the protein being the conformation with the lowest energy level, the global minimum of the landscape (24). The landscape is drawn as a rugged funnel shape in a three-dimensional system with the free energy on the y axis and the conformational space or entropy as a two-dimensional projection on the x and z axes. Indeed, a computer simulation based on experimental structural information of the acylphosphatase protein has demonstrated the usability of the model (25) .
Because the free energy of a protein is a function of its conformation defined by the interactions between the amino acid residues, even small alterations in the amino acid chain may change the surface of the landscape, leading to the possible formation of new local freeenergy minima or, in the extreme case, formation of a new global free-energy minimum resulting in a different stable structure of the protein, which may be prone to aggregation. This implies that the native state of a protein is not always the global energy minimum. To refine the concept of energy folding landscapes to include the aggregation tendency, which may be aggravated by extrinsic factors, such as high protein concentration and elevated temperature, in the living cell, one can imagine a landscape with two deep valleys (23). The idea is visualized in Figure 1 .
Protein aggregates can be extremely stable, even more stable than the native protein, suggesting that the aggregated states are trapped in the kinetically deepest valleys of the landscape. It is therefore rationalized that the decision of folding toward an aggregated or native state is a battle between conformations stabilized by intermolecular and intramolecular interactions, respectively (23).
Furthermore, amino acid substitutions in the protein tend to raise the local minimum around its native state, rendering the stabilization more cumbersome and increasing the risk of assuming misfolded conformers with enhanced aggregation tendency. Molecular chaperones play a vital role in this battle by rearranging structures forming interactions to other proteins or by exposing hydrophobic regions and thereby lifting them to a higher C h a p er one fo ld in g C h a pe rone ho ld in g Fr ee en erg y U n fo ld in g
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Figure 1
Free-energy folding landscape for chaperone-mediated protein folding: hypothetical landscape of all possible protein conformations pictured with higher altitude in the airspace symbolizing higher free energy and entropy. Chaperones iteratively bind and release their substrates, each time raising the free energy and enabling escapes from wrong folding pathways, indicated by the "Unfolding" arrow. Eliminating protein by degradation can, in principle, take place from any location in the landscape, but occurs predominantly in areas with trapped misfolding or on pathways toward aggregated structures, as indicated in the aggregation funnel. (89) . A pertinent question, therefore, is: Will a given variant lead to misfolding of the protein? Because of a lack of knowledge about the folding pathway of proteins, there is not yet a satisfactory answer to this question. However, a number of resources are available through the Internet, allowing the user to test different protein variants to produce an "educated guess" related to the pathogenic effect of the given variant. The most promising resources today include the PolyPhen (71), Fold-X (43), SIFT (67) , and PMUT (32) programs. The predictions can be done based on sequence alignment with orthologs and paralogs in addition to structural homology modeling based on experimentally determined structures. These programs can be used to indicate the effect of given amino acid substitutions for further evaluation. They can also be used to pinpoint regions of a protein more interesting than others to be included in experimental analysis or to give an overall evaluation of a larger number of variations, revealing a tendency in their damaging effect. However, although these programs are powerful tools, they should be used with caution, especially in the molecular genetic evaluation of "new" gene variations identified in patients with genetic diseases.
PROTEIN QUALITY CONTROL SYSTEMS
In the test tube, protein folding is performed most efficiently at low protein concentrations and low temperature. In contrast, protein folding in human cells takes place at 37
• C-or higher during fever-with very high concentrations of proteins (29). To sustain a reasonable efficiency of protein folding in this challenging environment and to protect against the negative consequences of environmental changes, PQC systems have evolved that supervise folding, counteract aggregation, and eliminate misfolded and damaged polypeptide chains before they can exert toxic effects. As discussed above, important components of these systems are comprised by molecular chaperones. Additionally, the PQC systems contain specialized intracellular proteases and accessory factors that regulate the activity of chaperones and proteases or provide communication between the various components. Figure 2 illustrates the principle of PQC. During or after synthesis or upon unfolding, proteins interact sequentially with different chaperones on their path to the native conformation. Some chaperones only interact with a subset of proteins. As long as binding sites on chaperones are available, folding intermediates can cycle between chaperone-bound and free states attempting to fold. However, they may also be captured by the degradative part of the PQC system and eliminated. Different chaperones have preferences for different partially folded conformations. For example, the Hsp70 chaperone binds extended unfolded protein chains, whereas the Hsp60 chaperone binds compact folding intermediates (35). Although there is some overlap and certain chaperones are able to fulfill several functions, one can distinguish between folding chaperones, holding chaperones, and unfolding chaperones. Folding chaperones promote folding, whereas holding chaperones, like the small heat-shock proteins lacking an ATPase activity, reversibly bind misfolded proteins. They need to transfer their substrates to folding chaperones to accomplish folding. Unfolding chaperones typically contain one or two so-called AAA + domains that harbor an ATPase, and are able to unfold misfolded proteins, either for degradation or to give them a new start for folding (59).
The proteases of PQC systems have a particular structure secluding the proteolytically active sites inside cavities that are not accessible for folded proteins (41) (see Figure 2) . To be degraded, proteins must first be fully unfolded before they are injected into the proteolytic cavities, where they are processively degraded into small peptides. This is typically accomplished by AAA + domain containing "unfolding chaperones." With respect to the proteasome, the most prominent protease of the cytosol, proteins to be degraded are selected by an ubiquitin-tagging system (see below). Other PQC proteases, e.g., those present in mitochondria, directly select their substrates using their chaperone domains or subunits (48). The compartmentation of the cellular PQC systems is indicated in 
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Figure 2
Functioning of protein quality control (PQC) systems. PQC systems manage the pool of unfolded and partially folded conformations (center). Folding chaperones promote folding, holding chaperones maintain solubility, and unfolding chaperones disaggregate aggregates or unfold misfolded proteins and inject them into proteolytic chambers of PQC proteases.
The production and maintenance of functional proteins, their turnover, and the removal of damaged and aberrant proteins are central tasks of PQC systems. Therefore, it is not surprising that interference with these cellular functions can lead to disease. Under normal conditions the PQC system can eliminate defective ribosomal products due to errors in translation or post-translational processes (81), as well as aberrant proteins originating from the load of gene variations present in the respective individual or from damage by covalent protein modifications like those elicited by reactive oxygen species (ROS) (27). Disturbances of the PQC by overload with misfolding variant proteins, environmental challenges, or gene variations in PQC components may thus trigger disease processes.
PQC systems are highly dynamic, consist of components with often redundant func-
ROS: reactive oxygen species
Hsc: heat-shock cognate tion, and react sensitively to the demands by increasing or decreasing the transcription and translation of their various components. A number of PQC genes are constitutively expressed at high level, e.g., the Hsc70 and Hsp60 chaperones and proteasome subunits; others are only expressed at a very low level under physiological conditions, but are strongly induced upon stresses of the folding system. Furthermore, it is increasingly recognized that additional factors link the folding and degradation machineries together and help in tuning PQC to the diverse demands (61). There may be tissuespecific differences in the ability to elicit the stress response and tune PQC, which may explain the fact that variations in proteins that are expressed in all tissues only give rise to cellular dysfunction in certain tissues. 
Figure 3
Schematic representation of the protein quality control systems in the cytosol, endoplasmic reticulum, and mitochondria.
TRiC: TCP-1 ring complex
ORGANELLE-SPECIFIC PROTEIN QUALITY CONTROL SYSTEMS AND PROTEIN MISFOLDING DISEASES
Protein Folding and Quality Control Systems in the Cytosol
The protein folding and PQC system of the cytosol comprises a large number of components constantly assembling and disassembling with their substrate. Upon emerging from the ribosome, nascent polypeptides are protected by chaperones, such as nascent-polypeptide-associated complex (NAC), Hsp40, Hsp70, prefoldin, and TCP-1 ring complex (TRiC), and held in a foldingcompetent state until released from the ribosome. Subsequently, most small proteins complete their folding in the cytosol without assistance, whereas a fraction of the cytosolic proteins requires further assistance from chaperones, e.g., Hsp90 and TRiC (45). TRiC, which is the most complex cytosolic chaperone, is composed of a double-ring structure, each with eight different subunits forming a large cavity in which the polypeptide is folded to a native or near-native form, and later released into the cytosol (87) . If the folding to the native structure cannot be completed the chaperones assess whether misfolded conformers should be refolded or degraded by the ubiquitin-proteasome pathway in order to eliminate toxic conformations (61). Targeting a polypeptide for degradation requires a multistep pathway to covalently attach ubiquitin monomers. Ubiquitin is activated by the ubiquitin-activating enzyme (E1), and transferred to an ubiquitin carrier protein (E2). The E2 enzyme and the polypeptide both bind to a specific ubiquitinprotein ligase (E3), and ubiquitin is covalently attached to the substrate. Further steps generate a polyubiquitin chain, targeting the polypeptide substrate to the proteasome for degradation (37). A typical mammalian cell contains one or a few different E1 enzymes, some tens of E2 enzymes, and several hundred different E3 enzymes, reflecting the specificity of targeted degradation in the mammalian organism. The integrated system of chaperones and the components of the ubiquitin-proteasome pathway comprise the most important cytosolic PQC system.
Failure of the PQC system to degrade misfolded proteins may lead to formation of protein aggregates. Aggregates in the cytosol may accumulate at a single, juxtanuclear site called an aggresome, or as soluble monomers and oligomers, which later may precipitate into long amyloid fibrils. Aggresomes are large globular deposits formed by retrograde transport of aggregated material along microtubular tracks in a highly ordered transportation system (52), whereas amyloid fibrils are long protein aggregates with a tube-like core region formed by the inherent properties of circular β-sheet structures (25). Accumulating data suggest that the fibrillar or aggresomal deposits may not be the primary toxic agent, but rather that the inherent pathogenicity resides in the soluble oligomers (13, 18, 49, 66) . By contrast, larger accumulations of aggregates may be a way to control the damage from the cytotoxic substances. In mammalian cells, larger aggregates are unspecifically degraded by the lysosomal autophagic pathway (55).
Cytosol-Associated Protein Misfolding Diseases
Defective folding caused by amino acid substitutions that result in rapid degradation of the variant protein is exemplified by phenylketonuria (PKU), an inborn error of phenylalanine metabolism. Amino acid substitutions in the phenylalanine hydroxylase (PAH) protein far from the enzyme's active site may cause misfolding of the protein, hinder formation of the active tetramer, and trigger rapid degradation. In many cases PKU is thus due to loss-of-function pathogenesis. An increase in the chaperone concentration or lowering of the temperature facilitates the protein folding and, at least in cell models, rescues the enzymatic activity of PAH (36). Aggregates containing the variant PAH protein have been found in bacterial lysate and in vitro mammalian studies (101) . Whether these aggregates are an epiphenomenon, or they perform a toxic gain-of-function effect in patients is unknown.
Only a few well examined gain-of-function diseases exist where the gene product of a mutated allele interacts with and inhibits the function of the normal allele product and thereby acts like a poisonous peptide in a dominant negative fashion. These disorders include certain cardiomyopathies as well as keratin and collagen diseases. For the skin disease epidermolysis bullosa simplex, diseaseassociated missense variations in the keratin-5 and keratin-14 genes lead to incorporation of misfolded keratin monomers into the keratin filament network, causing a mechanical instability. Ideally, the PQC system should detect and eliminate the misfolded monomers. However, external stress factors may reduce its efficiency and thereby trigger the manifestation of the phenotype. In addition to the poisonous peptide effect, accumulation of misfolded proteins may lead to aggregate formation, as observed in cardiomyopathies, which may add to the pathology (77, 96) .
A special case of protein misfolding diseases are those caused by variations in the fold-
PKU: phenylketonuria
PAH: phenylalanine hydroxylase
Loss-of-function pathogenesis: pathogenesis resulting from insufficient protein function due to inadequate protein synthesis, functional site amino acid alterations, or inability to achieve the functional protein structure because of misfolding
PD: Parkinson's disease
Gain-of-function pathogenesis: the misfolded protein accumulates/ aggregates in the cell, giving rise to new toxic functions related to physico-chemical properties
SOD1:
Cu,Zn-superoxide dismutase ing machinery itself, leading to reduced PQC efficiency. One example is desmin-related myopathy, where αB-crystallin, a small heatshock protein, plays a role in the folding of desmin, which has its function in the intermediate filaments of cardiomyocytes. This function, however, is compromised by a single amino acid substitution that leads to the formation of aggregates containing both desmin and αB-crystallin (98) . A similar effect is seen in patients with amino acid alterations in desmin itself, rendering the pathology of a direct protein misfolding pathogenesis most likely.
In Parkinson's disease (PD), protein aggregates are formed in the brain, leading to neurodegeneration (64) . Point mutations or increased dosage of the α-synuclein gene lead to a dominant form of the familial disease by a presumed toxic gain-of-function pathogenesis due to cytosolic aggregates consisting of either wild-type or variant α-synuclein, as well as components of the ubiquitin-proteasome system and other cellular proteins. Earlyonset recessive forms of PD are associated with variations in the PARKIN, UCH-L1, DJ-1, or PINK1 genes. These genes code for components involved in the ubiquitination and turnover of α-synuclein, and it is speculated that the pathogenesis includes a loss of PQC function, leading to α-synuclein aggregation in addition to general oxidative stress causing mitochondrial dysfunction (7). Post-mortem studies of sporadic PD samples reveal a general loss of activity in the ubiquitin-proteasomal system as well as signs of increased oxidative stress, implying that sporadic and familial PD evolve through the same fundamental mechanisms (64) .
The pathogenesis of amyotrophic lateral sclerosis (ALS) mediated by Cu,Znsuperoxide dismutase gene (SOD1) variations is believed to be gain-of-function through aggregation of the misfolded variant SOD1 protein. SOD1 protects the cell from oxidative damage by catalyzing the dismutation of the superoxide radicals to hydrogen peroxide and oxygen (11 
ERAD:
ER-associated degradation be a case of increased oxidative damage from enzymatic haploinsufficiency. However, artificial reduction of the enzymatic SOD1 activity does not mimic the ALS phenotype in animal models (10, 72) . In fact, several of the SOD1 variants remain fully active (8) . More than 100 disease-associated SOD1 gene variations are known, accounting for 25% of the familial ALS cases, which for the most part are transmitted in a dominant fashion. Several gained functions have been proposed for the variant proteins, such as aberrant chemistry of the Cu and Zn sites, loss of protein function through coaggregation with the aggregates, depletion of molecular chaperones, dysfunction of the proteasome overwhelmed with misfolded proteins, as well as disturbance of mitochondrion and peroxisome functions (11) .
A combined gain-of-function and loss-offunction may be a more widespread pathogenesis than presently acknowledged, and a dysfunctional effect from accumulation of aberrant proteins may in fact be present in many protein misfolding diseases (see below).
Protein Folding and Quality Control in the Endoplasmic Reticulum
The endoplasmic reticulum (ER) is the first compartment of the secretory pathway. It is engaged with ribosomal protein synthesis, coand post-translational modification, and protein folding. Proteins enter the organelle in an unfolded state and begin to fold cotranslationally. The ER lumen contains high concentrations of a specialized set of chaperones and folding enzymes, which assist protein folding in conjunction with post-translational modifications, e.g., signal peptide cleavage, disulfide bond formation, and N-linked glycosylation. In this respect, the ER plays a crucial role in the PQC, regulating the transport of proteins from the ER to the Golgi apparatus, as only proteins that have attained their native structure in the ER are exported efficiently (54). The primary PQC is applied to all proteins and relies on the recognition of hydrophobic sequences as well as the content of unpaired cysteine residues, immature glycans, and aggregation tendency. Interactions with components of the primary PQC, i.e., BiP, calnexin, calreticulin, glucose-regulated protein Grp94 and the thiol-disulphide oxidoreductases, protein disulphide isomerase (PDI), and ERp57 on one hand, assist protein folding, and on the other, serve as ER retention anchors. Misfolded or unassembled proteins initially display a prolonged association with the PQC components, but may accumulate in the absence of efficient ER-associated degradation (ERAD) (80) . Substrates for ERAD are selected by the PQC system and translocated to the cytosol, where they normally are degraded by the ubiquitin-proteasome system (63, 94).
The secondary PQC often relies on cellspecific factors and facilitates secretion of individual proteins or classes of proteins. It was demonstrated that the ER of mammalian cells allows the secretion of several pathogenic transthyretin variants with wildtype efficiency in spite of compromised folding and that only highly destabilized variants are subjected to ERAD and then only in certain tissues (82). These observations indicate that ER-assisted folding-in competition with ERAD-defines the unique secretory capacity of each tissue. The presence of such tissue-specific PQC could provide a possible general explanation for the development of tissue-selective protein misfolding diseases.
A substantial number of cellular proteins are processed and transported through the ER. These include receptors and ion channels to be expressed on the cell surface, enzymes and hormones to be secreted, as well as proteins with a specialized function within the organelles of the secretory pathway. Because many of these proteins are essential and indispensable in many physiological processes, a variety of disease phenotypes may result from impairment of their ER-mediated transport. A bioinformatics analysis showed that genes encoding proteins with ER-targeting signals are overrepresented in a large database of disease susceptibility genes compared with all genes predicting proteins in the human genome (45% versus 30%), suggesting that defective ER processing of proteins may contribute to numerous diseases (19).
Endoplasmic Reticulum-Associated Misfolding Diseases
ER-associated misfolding and rapid degradation by ERAD are hallmarks of cystic fibrosis (CF), which is a lethal autosomal recessive disease caused by mutations in the CF transmembrane conductance regulator (CFTR ) gene encoding a chloride channel. The disease results from loss of chloride regulation in epithelia expressing the gene. More than 1000 disease-associated CFTR gene variations have been described. However, one single variation, coding for an one-amino acid deletion variant, F508, is by far the most common, accounting for about 66% of all diseaseassociated variant CFTR alleles worldwide (6) .
CFTR maturation in heterologous expression systems seems to be a rather inefficient process by which only 25-30% of the newly synthesized wild-type protein reaches the plasma membrane (99) . In addition, certain amino acid substitutions appear to stabilize the protein but impair ion transport in such systems, thus it has been suggested that protein stability has been compromised for biological function during evolution (92) . Recently, however, it was observed that epithelial cells endogenously expressing CFTR actually efficiently process the protein to postGolgi compartments (97) , an observation that questions the structural instability model of wild-type CFTR and supports that epithelialspecific factors regulate both CFTR biogenesis and function (5) . For the F508 CFTR protein the maturation process is very inefficient and virtually all of the protein (>99%) undergoes rapid ERAD (58, 99).
Synthesis of CFTR occurs with its concomitant insertion in the ER membrane and attachment of Hsc70/Hsp70 to nascent cy-CFTR: cystic fibrosis transmembrane conductance regulator tosolic domains. The cell seems to use this Hsc70/Hsp70 control as the first checkpoint to assess CFTR conformation, and it has been proposed that it is the major mechanism to discard F508 CFTR (31). Prolonged retention of unfolded F508 CFTR by Hsc70 causes the variant protein to be degraded through ERAD. In contrast, wild-type CFTR proceeds in the folding pathway through interaction of its N-glycosyl residues with calnexin (31). Subsequently, it acquires its native conformation for ER export through successive rounds of de-and reglucosylation binding to calnexin. However, prolonged presence in the calnexin cycle may cause misfolded CFTR to become a target for ERAD.
Like CF, hereditary emphysema due to α-1-antitrypsin deficiency seems to involve ERassociated misfolding and rapid degradation. However, in certain individuals under particular conditions, accumulation of the variant protein causes cell damage in the liver (70) . α-1-antitrypsin is a major plasma serine protease inhibitor secreted by hepatocytes to regulate the proteolytic activity of various circulating enzymes. α-1-antitrypsin shows considerable genetic variability, having more than 90 naturally occurring variants (Pi types). Severe α-1-antitrypsin deficiency affects approximately 1 in 1800 newborns and 95% of these individuals are homozygous for the PiZ allele (E342K). E342K homozygotes are predisposed to premature development of pulmonary emphysema in adult life by a loss-of-function mechanism, i.e., lack of α-1-antitrypsin in the lung permits uninhibited proteolytic damage of the connective tissue matrix by neutrophil elastase (57). The E342K substitution reduces the stability of the monomeric form of the protein and increases its tendency to form polymers in vitro by the "loop-sheet" insertion mechanism. The abnormally folded and polymerized PiZ α-1-antitrypsin variant is retained in the ER of hepatocytes rather than being secreted into the circulation, thereby causing plasma deficiency of α-1-antitrypsin. It has been shown that the PiZ variant interacts with specific 78) , and it is known that degradation of the variant protein is mediated by several pathways including the proteosome, autophagy, as well as one or several nonproteasomal mechanisms (69) .
A subset of patients with homozygous PiZ α-1-antitrypsin deficiency develops chronic liver disease, usually during childhood. This condition appears to involve a toxic gain-offunction mechanism whereby retention and accumulation of the PiZ variant protein in the ER of the hepatocytes damage the cells by activating specific signal transduction pathways indicating apoptosis, proinflammation, and autophagy (46, 74, 91) .
A toxic gain-of-function pathogenesis related to misfolded proteins in the ER is also likely responsible for the development of autosomal dominant familial neurohypophyseal diabetes insipidus (FNDI). FNDI is characterized by polyuria caused by a deficient neurosecretion of the antidiuretic hormone, arginine vasopressin (AVP) (22). The AVP deficiency seems to develop gradually during the first years of life and is probably due to damaging of the AVP-producing magnocellular neurons in the supraoptic and paraventricular nuclei of the hypothalamus. FNDI has been linked to more than 50 different variations in the AVP gene (20, 84). It has been proposed that the variations lead to the production of a variant hormone precursor that fails to fold and/or dimerize efficiently in the ER and thus is retained by the ER PQC, resulting in cytotoxic accumulation of protein in the neurons. Heterologous expression in cell cultures and transgenic animals has showed that some disease-associated AVP gene variations may lead to the production of a variant AVP hormone precursor that, compared with the wild-type, is processed inefficiently into AVP, probably as a result of its retention in the ER (84) . In contrast, a variant of the protein causing a recessive form of FNDI, does not seem to affect the ER-mediated transport of the hormone precursor, but rather its final processing downstream of the ER (21). This observation may provide a relative control in support of the hypothesis that the dominant form of FNDI is caused by protein misfolding and accumulation of variant AVP precursor protein in the ER.
Variant AVP precursor proteins expressed in cell culture have been shown to be translocated to the cytosol and degraded by the proteasome, but ubiquitination could not be demonstrated (34). Actually, a significant portion of the primary translation products failed to enter the ER lumen at all. Both pathways of degradation, via the ER lumen and directly from the cytosol, were additionally found to some extent for the wild-type protein. It is not known whether cytosolic forms of the variant proteins trigger cytotoxicity in vivo. In a murine knock-in model of an FNDI mutation the progressive development of a typical diabetes insipidus phenotype was accompanied by an induction of BiP, as well as a specific and progressive loss of the AVP-producing neurons (75) . Furthermore, heterologous expression of an AVP variant protein in cell culture and transgenic animals has indicated that autophagy is involved in the pathogenesis (15, 16) .
Protein Folding and Quality Control in Mitochondria
Mitochondria represent a separate cellular compartment where-in humansapproximately 1500 proteins fold and are degraded (90) . Only 13 of the mitochondrial proteins are encoded by the mitochondrial DNA, the bulk is nuclear encoded, synthesized in the cytosol and subsequently imported into mitochondria. Import of mitochondrial proteins occurs mainly posttranslationally in an unfolded conformation through pores in the outer and inner mitochondrial membrane (102) . Many mitochondrial proteins, especially those of the matrix space, contain amino terminal extensions that counteract premature folding in the cytosol, direct the protein along the mitochondrial import machinery, and are cleaved off upon arrival in the mitochondrial matrix. Many proteins localized in the outer and inner membrane or the intermembrane space contain internal targeting signals that are not cleaved off.
Molecular chaperones in the cytosol like Hsp70 and Hsp90 keep newly synthesized mitochondrial proteins in an unfolded, import-competent conformation (104) . A mitochondrial Hsp70 homolog, the first representative of the mitochondrial PQC system, binds to the incoming polypeptide chain and is involved in the translocation process (102) . The mitochondrial PQC system comprises many orthologs to bacterial and yeast PQC systems including molecular chaperones like the mitochondrial Hsp70, the Hsp60/Hsp10 system, and a set of proteases with AAA + domains-resembling the proteasome-that are localized in the matrix or the inner membrane (48).
Mitochondria-Associated Protein Misfolding Diseases
A large number of recessively inherited genetic diseases resulting in loss-of-function due to variations in genes encoding mitochondrial metabolic enzymes have been described. In many cases, variations are of the missense type and affect the folding propensity of the protein and/or the stability of the native conformation. A typical and extensively studied example is medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (38). The MCAD enzyme, a homotetramer with FAD as cofactor, is involved in mitochondrial fatty acid β-oxidation. One prevalent amino acid substitution, K304E, is responsible for approximately 90% of the disease-associated alleles in patients with clinical symptoms, and its effects have been studied in detail (38). The K304E variant protein is synthesized and imported into mitochondria at normal levels, but is strongly impaired in folding and assembly. Folding of the MCAD protein occurs through successive interaction with mitochondrial Hsp70 and the mitochondrial chap-
MCAD:
medium-chain acyl-CoA dehydrogenase SCAD: short-chain acyl-CoA dehydrogenase erone Hsp60. The K304E variant protein has been shown to remain associated with Hsp60 for prolonged time periods (76) . An important finding was that the residual level of the natively folded K304E variant enzyme could be strongly modulated by environmental conditions like temperature and availability of chaperones (9) . Analysis of the purified fraction of the K304E variant protein that folded to the native state after expression under permissive conditions revealed only slightly altered enzymatic parameters and a decreased thermal stability (51). Similar studies with other disease-causing MCAD variations and other mitochondrial enzyme deficiencies due to missense variations (47) underline that impaired folding is a major effect of diseaseassociated missense variations.
Deficiency of short-chain acyl-CoA dehydrogenase (SCAD), a mitochondrial homolog of MCAD with specificity for shorter chain length is due to variations in the SCAD gene. Mostly missense disease-associated variations have been identified, and experimental analysis of a set of variant proteins showed that all display prolonged interaction with the Hsp60 chaperone (68) . Like that observed for MCAD, some of the variant proteins are unable to form active enzyme whereas others form active tetramers with efficiency depending on the folding conditions. An interesting observation of the analysis was that some of the variant proteins have a strong tendency to aggregate inside the mitochondria and that this tendency was increased at elevated temperature. This phenomenon raises the possibility that aggregation may play a role in the pathogenesis of SCAD deficiency. In this and other instances one may envisage that both loss-of-function due to degradation of misfolding variant proteins and a gain-of-function pathogenesis due to formation of toxic accumulated misfolded proteins may coexist, and that secondary genetic or environmental conditions determine the balance between these.
In hereditary spastic paraplegia, a lateonset degenerating disease resulting from www.annualreviews.org • Protein Misfolding Diseasesdysfunction of the very long axons of the motor neurons that control voluntary movements of the legs, disease-associated variations have been detected in two genes encoding mitochondrial PQC components. One is paraplegin, a subunit of the membrane-bound AAA + domain containing protease, and the other is Hsp60, a chaperone of the mitochondrial matrix (14, 44) .
Paraplegin coassembles with AFG3L2 to a protease complex in the inner mitochondrial membrane. In the absence of a functional paraplegin gene, like in some spastic paraplegia patients, the AFG3L2 subunit assembles to homo-oligomeric complexes that apparently have residual function providing sufficient protease and PQC function under most circumstances (3), but apparently not under those present in very long axons.
Only one disease-associated variation has so far been identified in the HSP60 gene. It is a missense variation that abolishes the capacity of Hsp60 to functionally replace the bacterial homolog GroEL in an Escherichia coli experimental system (44). Investigations with the bacterial homolog GroEL indicate that a relatively small portion of E. coli's proteins require interaction with GroEL for folding and that a number of other proteins are partially dependent (50). Hsp60 is an essential gene in flies and yeast. Considering the oligomeric, sevenmer ring architecture of the Hsp60 chaperone complex, incorporating defective mutant subunits that have a dominant negative effect on the function would be expected to totally abolish Hsp60 chaperone function. The HSP60 gene variation associated with spastic paraplegia thus appears to disturb Hsp60 chaperone function in a subtle way that only manifests in certain cells.
CELLULAR CONSEQUENCES OF PROTEIN MISFOLDING
The conceptional framework of protein misfolding diseases comprising loss-of-function and gain-of-function pathogenic mechanisms is a practical one in the process of understanding the biochemistry and cell biology as well as in developing strategies for treating these diseases. However, the effect of gene variations and damaging modifications in a given protein is very complex and variable over time in the same individual or between individuals. Indeed, with special relevance for genetic diseases, gene variations may, in addition to creating an insufficiency of protein function, at certain times, e.g., late in life or under cell stress conditions, give rise to a gain-of-function pathogenesis due to insufficient elimination of misfolded proteins. Although the specific biochemistry and cellular pathology-caused by a loss of protein function-is important for diagnosing and treating the individual diseases, the contribution from the cellular disturbances, which are elicited by accumulated and aggregated cellular proteins, may thus be as important. It may vary from insignificant to being the determinant pathogenetic factor, depending on the balance between correct folding, misfolding, degradation, and accumulation of a given variant or damaged protein. In turn, this balance is determined by the nature of the protein in question, the cellular compartment in which the misfolding occurs, the efficiency of the relevant PQC system, the interacting genetic and chemical factors, as well as the cell and environmental stress conditions. Despite these variables, the cellular consequences-mild or severe-may be discussed within a common framework defined by simple physico-chemical properties of the proteins, such as hydrophobicity and charge, which may engage the misfolded proteins in unproductive and toxic protein-protein interactions (88) .
Within this common framework it is possible to distinguish between four levels of cellular reactions. The first is the immediate reaction and effort of the cell to clear it from misfolded proteins. The second involves cellular perturbations elicited by noncleared misfolded proteins, which may have assembled into oligomeric and polymeric forms. The third is the induction of further protection mechanisms against these perturbations, and the fourth is elimination of the cell. The various mechanisms, as they are indicated in Figure 4 , are not exclusive, but may be interconnected in sequences of events depending on the load of insults as well as other factors, such as type and age of the affected cells.
As discussed previously, PQC systems have evolved to protect the cells from unwanted translation products, as well as damaged proteins, all of which may misfold. If the load of misfolded proteins increases, a set of protective response mechanisms induces the expression of chaperones and proteases, as well as reduces the general protein synthesis to alleviate the load (73, 80, 93, 105) . In all cases, the mechanisms-at least partly-are governed by an imbalance between occupied chaperones (Hsp70s and Hsp90s) and regulatory proteins, such as inositol requiring kinase 1 (IRE1) and protein kinase-like ER kinase (PERK) in the ER (80), heat-shock factors in the cytosol (73) , and yet unknown factors in the mitochondria (105) .
In the young and healthy cell these mechanisms can cope with the load. But if the misfolded protein is slowly degradable or aggregation prone, or if cell stress is intense and long lasting or the cell has decreased degradation capacity, the misfolded protein may accumulate and affect a large number of cellular functions.
Because the ubiquitin-proteasome system is involved in the turnover of many cellular proteins and degradation of aberrant polypeptides, an efficient function of this system is very important for the clearing function of the ER and cytosolic PQC systems. Inhibitions of the proteasomal activity by misfolded proteins have been shown (4, 42) , as has decline of the efficiency by accumulation of aberrant ubiquitin (62). In addition to an inefficient degradation capacity to cope with the misfolding load, a sequestration of components of the ubiquitin-proteasome system, including ubiquitinated proteins, as well as other chaperones, proteases, and a number of other The fate of misfolded proteins and some important cellular consequences of accumulated proteins.
IRE1: inositol requiring kinase 1
PERK: protein kinase-like ER kinase cellular constituents, such as transcription factors, has been observed in a number of protein misfolding diseases (11, 26, 52, 65, 83) . This indicates that sequestration of chaperones and other vital factors may be a pathological mechanism, at least in some cases. The fact that we and other researchers have shown that misfolded variant metabolic enzymes during their processing in mitochondria or the cytosol are more dependent on chaperone assistance than the wild-type protein (1, 9, 36, 40, 68) , as well as the indication that increased oxidation and impaired protein degradation in old age may result in so-called chaperone overload (86) , strengthen the case. Another type of pathogenesis leading to cell dysfunction is fibril formation, which has been suggested to account for many of the mechanisms leading to cell dysfunction and death in the traditional neurodegenerative conformational diseases (17) . Oligomeric misfolded precursors to amyloid plaques have been shown to build into membranes (18) and form pores with devastating consequences for membrane-associated functions, such as ion transport, glutamate homeostasis, oxidative metabolism, and cell viability (12, 13, 17, 18) . Additionally, it has been shown that α-synuclein may form oligomers, which
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OXIDATIVE CELL STRESS
Misfolded proteins are only one internal stressor which induces cell stress. Another related stressor is aging, where PQC systems lose efficiency and misfolding occur. A characteristic for misfolding stress is the creation of oxidative stress. Since it has been suggested that the pathogenesis in diseases like diabetes, cardiovascular diseases, depression, and cancer, is related to oxidative stress, it is reasonable to suggest that protein overload/oxidative stress is a very general mechanism, which normally is counteracted by induction of PQC systems and antioxidant/autophagy systems. The mechanistic link between misfolded proteins and oxidative stress is therefore of great scientific and practical interest. fragment the Golgi apparatus (17) . Whether intramitochondrial misfolded proteins can form membrane-inserted fibrils is not known, but accumulated misfolded variant SOD1, which is located-at least partly-in the intermembrane mitochondrial space, has been shown to elicit a whole range of damaging mechanisms, including production of ROS and damage to several respiratory chain enzyme complexes (11) . This is probably initiated by calcium overload, an important pathologic mechanism in neurodegeneration (53). Calcium overload stimulates oxidative metabolism and induces the creation of oxidative stress as well as disturbs the glutamate metabolism resulting in excitotoxicity (30). A consequence of oxidative stress is the creation of oxidatively modified proteins (95) , which are prone to misfolding and blockage of the degradation systems, most notably the ubiquitin-proteasome system, which through the mechanisms mentioned will create additional oxidative stress, initiating a vicious cycle (see also Oxidative Cell Stress).
To suppress the development of cell damage, due in particular to oxidative stress, the cells possess a number of defense systems, which in the present context are the antioxidant systems (100, 103) and autophagic system (55), the functions of which are, respectively, to detoxify ROS and eliminate damaged cell domains, e.g., dysfunctional mitochondria (85) . When the defense systems fail to sustain cell health the final mechanism where all dysfunctions meet is cell death, either as apoptosis or necrosis (79) .
Although a great deal about the effects of misfolded proteins on various cellular functions is known, there are still many unanswered questions. A subject that was only touched on here, and on which there is an extensive literature, is the signal transduction pathways, which mediate the various effects and the relation between them. Space limitations have not allowed a discussion of these molecular mechanisms, but many are mentioned and referred to in the review papers cited here.
CONCLUDING REMARKS
Broadening the concept of protein misfolding diseases from the traditional conformational or aggregation diseases to encompassing many inherited disorders where missense gene variations render the variant protein unstable, either as folding intermediate or in the native state, is changing the scientific approach to elucidating the pathogenic and cell pathologic mechanisms of many diseases. From approaching the diseases from a purely biochemical and genetic perspective, where protein deficiency and substrate/ligand accumulation are viewed as the sole causes of the cell pathology and clinical symptoms, we are beginning to understand some of these disorders from a cell biological viewpoint. Ten to twenty years ago, when disease-associated gene variations were discovered in many genetic diseases, it was believed that genotypephenotype relationships could be established in most genetic diseases. This turned out to be too optimistic. In most genetic diseases no clear genotype-phenotype relationship can be established. There are many reasons for this, but one of them seems to be that missense variations give rise to misfolded variant proteins, the fates of which depend on many factors that may vary with time in different cells and from patient to patient. It has been demonstrated-at least in model systemsthat the efficiency of the PQC systems is of prime importance in this respect. It is also reasonable to suppose-as has been shown in a number of diseases-that common gene variations in other factors implicated in processing variant or damaged proteins may contribute to disease expression and development. In this respect, using transcriptomic and proteomic technologies should help in dissecting the cell pathology of many genetic disorders as well as elucidating the sequence of pathogenic and pathological mechanisms in the age-related protein misfolding diseases.
SUMMARY POINTS
1. Protein folding is accomplished by intramolecular forces and passes through intermediates with decreasing energy and entropy striving toward an energy minimum.
In vitro, folding intermediates may go off the pathway and use intermolecular forces, resulting in aggregation. In vivo, the folding process is assisted by molecular chaperones, which shield the proteins and guide them to the native structure.
2. Aberration in the amino acid chain, either by inherited gene variations or from damage to amino acids, such as oxidative modifications, may compromise folding, even in the presence of chaperones. Intracellular proteases, which together with the chaperones comprise the cellular protein quality control systems, try to eliminate misfolded proteins. For certain proteins and under certain circumstances elimination is inefficient and the misfolded protein accumulates as aggregates.
3. Aberrant proteins, which are prematurely eliminated by proteases, may give rise to loss-of-function pathogenesis and result in protein deficiency disease. Aberrant proteins, which are not eliminated but accumulated, result in gain-of-function pathogenesis and disease pathology. Some diseases show both loss-of-function and gain-offunction pathogenic mechanisms.
4. Typical diseases due to predominantly loss-of-function pathogenesis are phenylketonuria, cystic fibrosis, the pulmonary form of α-1-antitrypsin deficiency, and medium-chain acyl-CoA dehydrogenase deficiency. Typical diseases with predominantly gain-of-function pathogenesis are cardiomyopathies, keratin and collagen disease, Parkinson's disease due to α-synuclein gene variations, familial neurohypophyseal diabetes insipidus, and the liver form of α-1-antitrypsin deficiency. Mixed pathogenesis is seen in Parkinson's disease due to deficiency of the elimination systems, and indicated in short-chain acyl-CoA dehydrogenase deficiency.
5. Diseases with loss-of-function protein misfolding pathogenesis are typically autosomal recessively inherited, such as many metabolic disorders. In contrast, gain-of function pathogenesis most often results in dominant diseases, either due to poisonous peptides, such as in keratin and collagen diseases, or due to the cellular effects of the accumulated misfolded protein, such as those seen in Parkinson's disease with α-synuclein accumulation.
6. The effect of loss-of-function protein misfolding pathogenesis is typically insufficient of a metabolic or transport reaction as well as toxic effects of an accumulated substrate, which is unique for the particular cellular reaction. The effect of accumulated/aggregated proteins is more generally elicited by the physico-chemical properties and not by the specific function of the proteins.
7. Although the effect may be similar for different accumulated proteins, there are probably numerous factors, including cell types affected, which determine the pathology and severity of the insult. In particular, the expression level and the efficiency of the protein quality control systems in the specific cell type may be important. This renders aging cells in nondividing tissues, like muscle and brain, especially vulnerable to the consequences of protein misfolding.
FUTURE ISSUES TO BE RESOLVED
1. There is a need to develop quantitative bioinformatic tools to predict the effects of amino acid substitutions on the folding of a given protein.
2. There is a need for methods to determine the balance between elimination and accumulation of misfolded proteins, i.e., the efficiency of protein quality control systems, in order to elucidate the cell pathology and decide strategies for intervention.
3. Oxidative cell stress is a common phenomenon in protein misfolding diseases as well as in many other pathological conditions. Therefore, there is a need to elucidate the mechanistic links between accumulated misfolded proteins and mitochondrial dysfunction, which is the prime cause of oxidative stress. 
